G+FLASLIFE SCIENCES

G+FLAS Life sciences has been developing
CRISPR/Cas foundation technologies as well as
innovative applications for better human health,
including gene therapy drugs, biopharmaceuticals,
and novel seeds with desired traits.

Learn more

G+FLASLIFE SCIENCES

G+FLAS Life sciences has been developing
CRISPR/Cas foundation technologies as well as
innovative applications for better human health,
including gene therapy drugs, biopharmaceuticals,
and novel seeds with desired traits.

Learn more

G+FLASLIFE SCIENCES

G+FLAS Life sciences has been developing
CRISPR/Cas foundation technologies as well as
innovative applications for better human health,
including gene therapy drugs, biopharmaceuticals,
and novel seeds with desired traits.

Learn more

CRISPRGenome Editing Tech

An artificial CRISPR ribonucleoprotein (RNP) binds and cleaves
target DNA, which has the complementary sequence of sgRNA

more

PLANT NON-GMO CRISPRGenome Editing in Plants

An artificial CRISPR RNP binds
and cleaves target DNA in plants

more

BIOLOGICALSPlant-Based Biopharmaceutical Production

Biologicals, which produces massively through microbiome and
culture cells by recombinant DNA technology

more

News

Contact Us

Suite 1F, 38 Nakseongdae-ro, Gwanak-Gu, Seoul 08790, Korea

Learn more